Cosmos Health Inc (COSM)

$0.21 -0.01 (-5.10%)
Market Cap 13.30M
Revenue (ttm) 65.27M
Net Income (ttm) -19.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 21.26
Profit Margin -29.34%
Debt to Equity Ratio 0.46
Volume 1,450,945
Avg Vol 11,685,136
Day's Range N/A - N/A
Shares Out 60.04M
Stochastic %K 84%
Beta 4.80
Analysts Strong Buy
Price Target $4.50

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogre...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece
Mmmm_
Mmmm_ Aug. 24 at 5:55 PM
$COSM There isn’t much time left until December. The stock needs to close above $1 for 10 consecutive trading days to avoid delisting, so realistically, it needs to recover to $1 before November 24. There are less than three months left. Realistically, if the stock remains at its current price into November, I would say there is a 95% chance that a reverse stock split will occur. To be honest, at this point, I would put the probability of a reverse stock split at over 80%. That’s how risky and unfavorable the current trend looks.
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:46 PM
$COSM 🎯🎯
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:45 PM
$COSM Actually mid November ... 10 straight business days by Dec 7, but who's counting 😉
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:43 PM
$COSM So they buy back up to 5M and add 20M or more to the float?
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:41 PM
$COSM they have until December, or else they will do a something - obviously delisting is not on the table they were in a quiet period. in the earnings release they said that buybacks are ongoing also we forget to discuss the fact that the $8 millon ATW note has been addressed in full and the company is registering record sales growth, announcing new deals all the time, accross the globe overall, things are looking good IMO
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:39 PM
$COSM The man with no favorable plan for retail ... just him, his family and his cronies!
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:37 PM
$COSM if they buyback more, which they hinted they will, can you please disappear? Do we have a deal?
0 · Reply
Mmmm_
Mmmm_ Aug. 24 at 5:36 PM
$COSM Even if the company were to sell its cryptocurrency holdings, I’m not so sure they would use the proceeds for share buybacks. Although the stock price is near historical lows, the company hasn’t made any share repurchases under its previously announced buyback program for over a month. There isn’t much time left to meet the requirements to avoid a delisting warning, either. For now, the overall situation and trend are looking quite unfavorable.
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:34 PM
$COSM Question for CEO Siokas @Akis1965 Have you stopped buying back shares since July 18th? If so ... why? Do you not believe in your own company ... or do you just think it still has to go lower?
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:32 PM
$COSM spot analysis. Owning$ETH.X $BTC.X is a nice booster. But so are the $15 million real estate assets which are predominantly debt free
0 · Reply
Latest News on COSM
Cosmos Health announces distribution agreement with Innova Healthcare

2026-08-20T13:35:20.000Z - 4 days ago

Cosmos Health announces distribution agreement with Innova Healthcare

Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term

Aug 20, 2026, 9:30 AM EDT - 4 days ago

Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway

Aug 19, 2026, 9:00 AM EDT - 5 days ago

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway

Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels

Jul 27, 2026, 1:05 PM EDT - 4 weeks ago

Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels

Cosmos Health expands Sky Premium Life distribution pact with Pharma Cell

2026-07-20T19:50:15.000Z - 4 weeks ago

Cosmos Health expands Sky Premium Life distribution pact with Pharma Cell

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Jul 20, 2026, 3:46 PM EDT - 4 weeks ago

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Jul 17, 2026, 2:55 PM EDT - 5 weeks ago

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 250,000 shares

2026-07-16T17:20:22.000Z - 5 weeks ago

Cosmos Health announces repurchase of additional 250,000 shares

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Jul 16, 2026, 1:15 PM EDT - 5 weeks ago

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 100,000 shares

2026-07-15T18:20:12.000Z - 5 weeks ago

Cosmos Health announces repurchase of additional 100,000 shares

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Jul 15, 2026, 2:15 PM EDT - 5 weeks ago

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Cosmos Health stock buyback expands to 4.49M shares

2026-07-14T18:45:10.000Z - 5 weeks ago

Cosmos Health stock buyback expands to 4.49M shares

Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases

Jul 14, 2026, 2:40 PM EDT - 5 weeks ago

Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases

Cosmos Health repurchases additional 215,000 common shares in open market

2026-07-13T19:05:14.000Z - 5 weeks ago

Cosmos Health repurchases additional 215,000 common shares in open market

Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases

Jul 13, 2026, 3:00 PM EDT - 5 weeks ago

Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases

Cosmos Health reports Libytec partnership to commercialize Diabit-IS X in Greece

2026-07-13T17:05:17.000Z - 6 weeks ago

Cosmos Health reports Libytec partnership to commercialize Diabit-IS X in Greece

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

Jul 13, 2026, 1:00 PM EDT - 6 weeks ago

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

Cosmos Health launches subscription model

2026-07-10T15:00:12.000Z - 6 weeks ago

Cosmos Health launches subscription model

Cosmos Health Launches Subscription Model

Jul 10, 2026, 10:55 AM EDT - 6 weeks ago

Cosmos Health Launches Subscription Model

Cosmos Health announces repurchase of additional 80,000 shares

2026-07-09T19:50:56.000Z - 6 weeks ago

Cosmos Health announces repurchase of additional 80,000 shares

Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases

Jul 9, 2026, 3:45 PM EDT - 6 weeks ago

Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 190,000 shares

2026-07-08T19:55:19.000Z - 6 weeks ago

Cosmos Health announces repurchase of additional 190,000 shares

Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases

Jul 8, 2026, 3:40 PM EDT - 6 weeks ago

Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 230,000 shares

2026-07-07T18:30:11.000Z - 6 weeks ago

Cosmos Health announces repurchase of additional 230,000 shares

Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases

Jul 7, 2026, 2:27 PM EDT - 6 weeks ago

Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases

Cosmos Health reports preliminary Q2 revenue $19.4M

2026-07-07T13:35:24.000Z - 6 weeks ago

Cosmos Health reports preliminary Q2 revenue $19.4M

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Jul 7, 2026, 9:29 AM EDT - 6 weeks ago

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Cosmos Health announces repurchase of additional 220,000 shares

2026-07-06T18:40:08.000Z - 6 weeks ago

Cosmos Health announces repurchase of additional 220,000 shares

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases

Jul 6, 2026, 2:30 PM EDT - 6 weeks ago

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases

Cosmos Health expands buyback with additional 770,000 share repurchase

2026-07-02T18:15:08.000Z - 7 weeks ago

Cosmos Health expands buyback with additional 770,000 share repurchase

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Jul 2, 2026, 2:10 PM EDT - 7 weeks ago

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

Jul 1, 2026, 11:05 AM EDT - 7 weeks ago

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

Cosmos Health authorizes up to $5M share repurchase program

2026-06-30T16:00:32.000Z - 7 weeks ago

Cosmos Health authorizes up to $5M share repurchase program

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

Jun 30, 2026, 11:55 AM EDT - 7 weeks ago

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

Cosmos Health signs distribution agreement with IMC

2026-06-26T16:35:09.000Z - 2 months ago

Cosmos Health signs distribution agreement with IMC

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Jun 26, 2026, 12:30 PM EDT - 2 months ago

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Cosmos Health’s Cana advances international patent application

2026-06-25T19:40:17.000Z - 2 months ago

Cosmos Health’s Cana advances international patent application

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada

Jun 25, 2026, 3:31 PM EDT - 2 months ago

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada

Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

Jun 24, 2026, 3:37 PM EDT - 2 months ago

Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

Cosmos Health to deploy AI-powered call center

2026-06-23T19:40:11.000Z - 2 months ago

Cosmos Health to deploy AI-powered call center

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Jun 23, 2026, 3:35 PM EDT - 2 months ago

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Cosmos Health builds contract manufacturing orderbook to over 25M units

2026-06-22T14:40:08.000Z - 2 months ago

Cosmos Health builds contract manufacturing orderbook to over 25M units

Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit

Jun 22, 2026, 10:30 AM EDT - 2 months ago

Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Jun 18, 2026, 3:34 PM EDT - 2 months ago

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Jun 17, 2026, 3:35 PM EDT - 2 months ago

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Jun 17, 2026, 9:27 AM EDT - 2 months ago

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Jun 15, 2026, 9:00 AM EDT - 2 months ago

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Cosmos Health’s Cana wins contract manufacturing orders totaling 253,657 units

2026-06-12T19:40:29.000Z - 2 months ago

Cosmos Health’s Cana wins contract manufacturing orders totaling 253,657 units

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Jun 12, 2026, 3:33 PM EDT - 2 months ago

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Jun 12, 2026, 9:29 AM EDT - 2 months ago

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Jun 11, 2026, 3:31 PM EDT - 2 months ago

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Jun 10, 2026, 3:32 PM EDT - 2 months ago

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Jun 10, 2026, 9:00 AM EDT - 2 months ago

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Jun 9, 2026, 3:30 PM EDT - 2 months ago

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Jun 8, 2026, 10:00 AM EDT - 2 months ago

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Jun 5, 2026, 9:25 AM EDT - 2 months ago

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Jun 4, 2026, 3:57 PM EDT - 2 months ago

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Jun 4, 2026, 9:25 AM EDT - 2 months ago

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Jun 1, 2026, 8:25 AM EDT - 3 months ago

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

May 26, 2026, 9:34 AM EDT - 3 months ago

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

May 21, 2026, 2:20 PM EDT - 3 months ago

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

May 21, 2026, 9:15 AM EDT - 3 months ago

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

May 14, 2026, 9:00 AM EDT - 3 months ago

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 12, 2026, 10:15 AM EDT - 3 months ago

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

May 11, 2026, 2:25 PM EDT - 3 months ago

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

May 8, 2026, 11:25 AM EDT - 3 months ago

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Apr 30, 2026, 12:50 PM EDT - 4 months ago

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Apr 21, 2026, 12:50 PM EDT - 4 months ago

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Apr 20, 2026, 10:55 AM EDT - 4 months ago

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Apr 17, 2026, 2:00 PM EDT - 4 months ago

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Mmmm_
Mmmm_ Aug. 24 at 5:55 PM
$COSM There isn’t much time left until December. The stock needs to close above $1 for 10 consecutive trading days to avoid delisting, so realistically, it needs to recover to $1 before November 24. There are less than three months left. Realistically, if the stock remains at its current price into November, I would say there is a 95% chance that a reverse stock split will occur. To be honest, at this point, I would put the probability of a reverse stock split at over 80%. That’s how risky and unfavorable the current trend looks.
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:46 PM
$COSM 🎯🎯
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:45 PM
$COSM Actually mid November ... 10 straight business days by Dec 7, but who's counting 😉
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:43 PM
$COSM So they buy back up to 5M and add 20M or more to the float?
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:41 PM
$COSM they have until December, or else they will do a something - obviously delisting is not on the table they were in a quiet period. in the earnings release they said that buybacks are ongoing also we forget to discuss the fact that the $8 millon ATW note has been addressed in full and the company is registering record sales growth, announcing new deals all the time, accross the globe overall, things are looking good IMO
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:39 PM
$COSM The man with no favorable plan for retail ... just him, his family and his cronies!
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:37 PM
$COSM if they buyback more, which they hinted they will, can you please disappear? Do we have a deal?
0 · Reply
Mmmm_
Mmmm_ Aug. 24 at 5:36 PM
$COSM Even if the company were to sell its cryptocurrency holdings, I’m not so sure they would use the proceeds for share buybacks. Although the stock price is near historical lows, the company hasn’t made any share repurchases under its previously announced buyback program for over a month. There isn’t much time left to meet the requirements to avoid a delisting warning, either. For now, the overall situation and trend are looking quite unfavorable.
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:34 PM
$COSM Question for CEO Siokas @Akis1965 Have you stopped buying back shares since July 18th? If so ... why? Do you not believe in your own company ... or do you just think it still has to go lower?
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:32 PM
$COSM spot analysis. Owning$ETH.X $BTC.X is a nice booster. But so are the $15 million real estate assets which are predominantly debt free
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:30 PM
$COSM are you serious?? They bought back over 5 millon share in less than 2 months
0 · Reply
Mmmm_
Mmmm_ Aug. 24 at 5:30 PM
$COSM “There have been no share repurchases since July 18.”
1 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:29 PM
$COSM All this crooked CEO has to do is to buy 1 share and that counts as still buying back lol
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:28 PM
$COSM Even if they sell at a loss, they will raise hot cash to finance different stuff, or perhaps do even more buybacks!!
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 5:27 PM
$COSM For every small buy there's 3 large sells just waiting. So you see, this can't go up and STAY up.
0 · Reply
Skoufa
Skoufa Aug. 24 at 5:27 PM
$COSM Yes! they said in the previous buyback PR that they are continuing open market repurchases!!!
0 · Reply
ro_e_schi
ro_e_schi Aug. 24 at 5:25 PM
$COSM we need a buyback update. Are they still buying?
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 4:20 PM
$COSM Does anyone know what happened to the promised update this CEO @Akis1965 was supposed to give on this supposed weight loss pill in 1st or 2nd quarter of 2026? My guess is that it couldn't have been good news hence the 🦗🦗🦗
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 4:11 PM
$COSM Low of the day no matter when I look.
0 · Reply
Stopcryin
Stopcryin Aug. 24 at 4:10 PM
$COSM Buying that ETH back in Oct of last year at around $4K is killing this company!
0 · Reply
Mmmm_
Mmmm_ Aug. 24 at 4:05 PM
$COSM The reality is that the cryptocurrency holdings on the company’s balance sheet are also showing losses. The company’s losses have more than doubled, while the stock price is at an all-time low, and there isn’t much time left. I would say this is a particularly risky period.
0 · Reply
El_Stocks
El_Stocks Aug. 24 at 3:55 PM
Looking at $COSM results it is evident they are heading in the right direction, breaking sales / revenue records and improving cash flow. Besides the buyback and insider purchases, what caught my attention is their non-core assets. The real estate portfolio has huge value relative the the market cap and company size, but its illiquid. The crypto assets, on the other hand, are highly liquid, as good as cash. As some commentators have posted, both Bitcoin and Ethereum $BTC.X and $ETH.X are booming right now. This is an amazing liquidity boost for such a small company. The size of their crypto portfolio could fetch around $5 million if the previous crypto highs are reached , and much more if we have new records.
0 · Reply